As of June 2, 2025, Biotech Growth Trust PLC (BIOG.L) reports a Current Ratio of 0.33.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Biotech Growth Trust PLC's Current Ratio
Over recent years, Biotech Growth Trust PLC's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-03-31 | 0.33 |
| 2023-03-31 | 0.11 |
| 2022-03-31 | 0.00 |
| 2021-03-31 | 0.13 |
| 2020-03-31 | 0.07 |
This slight upward trend highlights how Biotech Growth Trust PLC manages its short-term assets and liabilities over time.
Comparing Biotech Growth Trust PLC's Current Ratio to Peers
To better understand Biotech Growth Trust PLC's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Biotech Growth Trust PLC (BIOG.L) | 0.33 |
| Standard Life Private Equity Trust PLC (SLPE.L) | 11.29 |
| Jpmorgan Global Growth & Income PLC (JGGI.L) | 7.11 |
| Ruffer Investment Company Ltd (RICA.L) | 5.53 |
| Foresight Solar Fund Ltd (FSFL.L) | 5.18 |
| BH Macro Ltd (BHMG.L) | 5.02 |
Compared to its competitors, Biotech Growth Trust PLC's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.